The question that needs to be resolved is what exactly is happening in terms of product filing and why is Ranbaxy saying that the product filings have not been impacted, says Vikas Dandekar, India Bureau Chief, PharmAsiaNews.Com.
first published: Sep 16, 2013 11:16 am
A collection of the most-viewed Moneycontrol videos.

Investing for a new era | LIVE conversation with Mukesh Ambani & Larry Fink

Live: Nifty rebounds 200 pts from day's low; Anthropic's AI tool triggers IT meltdown | Closing Bell

Will Nifty's Upward March Take A Pause As Sentiment Around IT Stocks Weakens? Opening Bell Live

India–US Trade Deal Is Here! Markets Explode, Rupee Soars | What Changes Now?
You are already a Moneycontrol Pro user.